HIPRA

Azienda Premium

241 Chi ti segue 9 Pubblicazioni 3 Seguendo

HIPRA is a biotechnological pharmaceutical company focused on prevention for animal and human health, with a broad range of highly innovative vaccines and an advanced diagnostic service.

A company that works with the latest technological advances to create innovative solutions that improve world health.

R&D projects are the basis of the knowledge. HIPRA has more than 50 years of experience dedicated to the research and development of different vaccines. With a unique organizational model, HIPRA controls all the processes of the value chain, generating singular know-how and becoming a reference in the research, production, and commercialization of biologics.

HIPRA has a solid international presence, commercial subsidiaries and a global distribution network, allowing products to reach costumers from more than 100 countries, covering the 5 continents.

Actinobacillosi / Pleuropolmonite suina Aujeszky Vaccini stabulogeni Circovirus-PCV Clostridiosi Colibacillosi Glaesserella parasuis/malattia di Glässer Influenza Mal Rosso /Erisipela Micoplasma/polmonite enzootica Parvovirus PRRS Rinite Atrofica Software

Inviare un messaggio

https://www.hipra.com

hipra@hipra.com

+34 972430660

Av. La Selva, 135
17170 GIRONA
Spagna

HIPRA

241 Chi ti segue 9 Pubblicazioni 3 Seguendo

Attività Prodotti 17 Eventi 1 Pubblicazioni 9 Articoli sponsorizzati su 3tre3 76

Key considerations for managing neonatal diarrhea: A practical approach

Neonatal diarrhea in piglets is a critical challenge in swine production. This practical webinar will address key prevention and management strategies to effectively control this disease.

Evento registrato